{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:10:20Z","timestamp":1773148220269,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C570\/A16491"],"award-info":[{"award-number":["C570\/A16491"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K02700X\/1"],"award-info":[{"award-number":["MR\/K02700X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bone.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T16:53:00Z","timestamp":1554483180000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-907X","authenticated-orcid":false,"given":"Clare J.","family":"Wotton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda E.G.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Floud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Beral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian K.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.04.003_bb0005","author":"NHS Digital"},{"issue":"9","key":"10.1016\/j.bone.2019.04.003_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00228-007-0320-6","article-title":"Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005","volume":"63","author":"Watson","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2019.04.003_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2016.10.013","article-title":"Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity","volume":"94","author":"van der Velde","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2019.04.003_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00228-009-0746-0","article-title":"Prescription of anti-osteoporosis drugs during 2004\u20132007-a nationwide register study in Norway","volume":"66","author":"Devold","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bone.2019.04.003_bb0025","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/jgs.14911","article-title":"Long-term Oral bisphosphonate therapy and fractures in older women: the Women's Health Initiative","volume":"65","author":"Drieling","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"10.1016\/j.bone.2019.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/jbmr.2918","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.003_bb0035","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcb.25266","article-title":"Risks and benefits of bisphosphonate therapies","volume":"117","author":"Reyes","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.bone.2019.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2019.04.003_bb0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2019.04.003_bb0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bjoms.2014.11.008","article-title":"United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis","volume":"53","author":"Rogers","year":"2015","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"34","key":"10.1016\/j.bone.2019.04.003_bb0060","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bone.2019.04.003_bb0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bone.2019.04.003_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.bone.2019.04.003_bb0080","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2019.04.003_bb0090","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2013-4119","article-title":"The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene","volume":"99","author":"Chiu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ije\/dyy065","article-title":"Cohort profile: the million women study","volume":"48","author":"Green","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bone.2019.04.003_bb0100","author":"CPRD"},{"issue":"3","key":"10.1016\/j.bone.2019.04.003_bb0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ije\/dyw060","article-title":"Data resource profile: the Scottish National Prescribing Information System (PIS)","volume":"45","author":"Alvarez-Madrazo","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bone.2019.04.003_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37664","article-title":"Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register","volume":"5","author":"Bergdahl","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.bone.2019.04.003_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/CLEP.S45226","article-title":"Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients","volume":"5","author":"Gammelager","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sim.1485","article-title":"Improved estimates of floating absolute risk","volume":"23","author":"Plummer","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.bone.2019.04.003_bb0125","series-title":"Health and Deprivation. Inequality and the North","author":"Townsend P","year":"1987"},{"key":"10.1016\/j.bone.2019.04.003_bb0130","series-title":"Stata Statistical Software: Release 13","author":"StataCorp","year":"2013"},{"key":"10.1016\/j.bone.2019.04.003_bb0135","first-page":"325","article-title":"Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis","volume":"6","author":"Pazianas","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"issue":"8","key":"10.1016\/j.bone.2019.04.003_bb0140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pds.3292","article-title":"Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis","volume":"21","author":"Tennis","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.bone.2019.04.003_bb0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.joms.2011.02.093","article-title":"Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study","volume":"70","author":"Vestergaard","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2019.04.003_bb0150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00198-012-2013-y","article-title":"Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures","volume":"24","author":"Lapi","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"9 Suppl","key":"10.1016\/j.bone.2019.04.003_bb0155","doi-asserted-by":"crossref","first-page":"212s","DOI":"10.1177\/0022034515587862","article-title":"A large national cohort study of the association between bisphosphonates and osteonecrosis of the jaw in patients with osteoporosis: a nested case-control study","volume":"94","author":"Kwon","year":"2015","journal-title":"J. Dent. Res."},{"issue":"10","key":"10.1016\/j.bone.2019.04.003_bb0160","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00198-017-4132-y","article-title":"Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users","volume":"28","author":"Eiken","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2019.04.003_bb0165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00198-013-2575-3","article-title":"Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis","volume":"25","author":"Lee","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2019.04.003_bb0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"issue":"5","key":"10.1016\/j.bone.2019.04.003_bb0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bjoms.2015.10.036","article-title":"Epidemiological study of alendronate-related osteonecrosis of the jaw in the southeast of Scotland","volume":"54","author":"Sammut","year":"2016","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2019.04.003_bb0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2012.08.115","article-title":"Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan","volume":"51","author":"Yamazaki","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2019.04.003_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch. Osteoporos."},{"issue":"8","key":"10.1016\/j.bone.2019.04.003_bb0190","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00198-015-3176-0","article-title":"FRAX-based assessment and intervention thresholds\u2014an exploration of thresholds in women aged 50 years and older in the UK","volume":"26","author":"McCloskey","year":"2015","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:43:03Z","timestamp":1757612583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219301310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"alternative-id":["S8756328219301310"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.003","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}